Jump Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.24M Buy
+55,659
New +$9.13M 0.12% 192
2025
Q4
Sell
-20,145
Closed -$1.89M 2128
2025
Q3
$1.89M Buy
+20,145
New +$1.42M 0.02% 756
2024
Q1
Sell
-4,274
Closed -$521K 2112
2023
Q4
$521K Buy
+4,274
New +$327K 0.02% 1041
2023
Q2
Sell
-10,669
Closed -$1.05M 1992
2023
Q1
$1.05M Sell
10,669
-48,703
-82% -$6.6M 0.04% 577
2022
Q4
$8.4M Buy
+59,372
New +$8.28M 0.44% 8

Other funds holding LABU

Jump Financial's LABU Position: Q1 2026 in Review

Jump Financial opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026: 55,659 shares worth $9.24M. The stake represents 0.12% of the portfolio and ranks #192 among its holdings. This is a return to the name: Jump Financial previously reported a position in LABU as recently as Q3 2025.

Jump Financial first reported a position in LABU in Q4 2022 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Jump Financial held 55,659 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $9.24M as of Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Jump Financial position in Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.12% of Jump Financial's portfolio in Q1 2026, its #192 holding.
  • Jump Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.